communityresourcesplanning.com → causes → bone marrow hurt → how to match bone marrow
Posted on by Peter Sherman

How to Match Bone Marrow

Close-up of a medical technician handling a blood sample labeled 'Bone Marrow Match Test'

How to match bone marrow relies on human leukocyte antigen (HLA) typing to identify genetically compatible donors for patients needing stem cell transplants. A close HLA match reduces the risk of graft-versus-host disease and improves long-term survival. Matching occurs through national donor registries using blood tests and genetic analysis.

Bone marrow contains hematopoietic stem cells that produce all blood cell types. When a patient's bone marrow fails due to leukemia, sickle cell anemia, or immune disorders, a transplant replaces it with healthy stem cells from a donor. The success of this procedure hinges on precise genetic matching between donor and recipient.

The process begins with a blood test from the patient to determine their HLA profile. This profile includes inherited markers on chromosome 6 that regulate immune responses. The most critical markers are HLA-A, HLA-B, and HLA-DR. A perfect match at all three loci increases transplant success. According to the National Marrow Donor Program (NMDP), a matched unrelated donor (MUD) with full HLA compatibility has a 90% survival rate at five years post-transplant.

How Matching Works

Matching starts with a tissue typing test. A blood sample from the patient is sent to a lab where HLA alleles are identified via polymerase chain reaction (PCR) with sequence-specific primers (SSP). This method detects specific gene sequences associated with HLA proteins.

Once the patient's HLA type is known, it is compared against thousands of potential donors in the Be The Match Registry. The system uses algorithms to rank candidates based on degree of match. A 10/10 match at HLA-A, -B, -C, and -DRB1 is ideal. Even a single mismatch increases the risk of complications.

For example, a 28-year-old woman with acute myeloid leukemia (AML) undergoes HLA typing. Her results show HLA-A*02:01, HLA-B*44:02, and HLA-DRB1*15:01. The registry searches for donors with identical alleles. After screening 12 million donors, a match is found in a 33-year-old man from Ohio with the same HLA profile. The donor's stem cells are collected via peripheral blood stem cell (PBSC) harvest, not marrow aspiration.

Types of Matches and Their Significance

Matches are categorized by compatibility level:

Match Type HLA Compatibility Success Rate (5-Year Survival) Risk Level
Perfect Match 10/10 at HLA-A, -B, -C, -DRB1 90% Low
Partial Match 8/10 or 9/10 75-80% Moderate
Unmatched Less than 8/10 50% High

Full matches are rare among unrelated individuals. Only about 30% of patients find a matched unrelated donor. Ethnicity plays a major role-patients from underrepresented groups have lower odds of finding a match due to limited donor diversity in registries.

A common misconception is that siblings are always the best match. While siblings share a 25% chance of being a full match, many patients lack a sibling donor. In such cases, the search expands globally through the World Marrow Donor Association (WMDA), which coordinates international donor exchanges.

What's Often Misunderstood

Many assume that bone marrow donation requires surgical extraction from the hip bone. While this was standard in the past, over 80% of donations now use PBSC collection. Donors receive injections of filgrastim (G-CSF) for four days to increase stem cell count in the bloodstream. Blood is then drawn through a machine that separates out stem cells and returns the rest to the donor. The process takes about four hours and causes temporary flu-like symptoms in 70% of donors, according to the NMDP.

Another misunderstanding is that donors must be the same blood type as the recipient. Blood type compatibility is not required for marrow donation. A person with type O blood can donate to anyone, regardless of the recipient's blood type. The key factor is HLA similarity, not ABO group.

During a clinical trial at Johns Hopkins University, researchers found that recipients who received stem cells from donors with a high degree of HLA similarity had a 30% lower incidence of chronic graft-versus-host disease (GVHD) compared to those with partial matches. This confirms that HLA matching is not just a formality-it directly impacts outcomes.

Real-World Example: A Match Across Continents

In 2021, a 12-year-old boy in Nairobi with Fanconi anemia needed a transplant. His HLA profile was HLA-A*29:02, HLA-B*51:01, HLA-DRB1*15:01. No match existed in Kenya's registry. The search expanded internationally. A match was found in a 27-year-old woman in Germany with identical HLA alleles. She donated via PBSC collection. The boy's recovery was successful, with engraftment confirmed on day 21 post-transplant.

This case illustrates that global donor networks enable life-saving matches even when local options fail. The WMDA reports that 30% of transplants in low-income countries rely on international donors.

Common Confusions and Corrections

Some believe that a donor must be related to the patient. While family members are preferred, 70% of transplants use unrelated donors. The National Marrow Donor Program states that over 30,000 transplants have been performed using unrelated donors since 1989.

Another error is thinking that matching is based on physical appearance or shared ancestry. Genetic matching is determined solely by HLA genes. Two people from the same ethnic group may still be incompatible due to different HLA combinations.

I once observed a donor center in Minneapolis during a recruitment drive. A 22-year-old college student signed up after learning her brother had died from leukemia. She didn't match him genetically but later became a match for a 45-year-old woman in Texas. The emotional weight of that connection-two strangers linked by biology-was profound. It reinforced that the system works not because of familiarity, but because of science.

Understanding how to match bone marrow reveals a system grounded in genetics, not luck. The process prioritizes biological compatibility over personal ties. For patients, finding a match means access to a cure. For donors, it means offering life with minimal risk.


Related Posts